Janus Henderson Investors
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Tenpoint Therapeutics
29 Jan 2026
Tenpoint Therapeutics unlocks a £170m Series B from investors to rejuvenate vision in the aging eye
Tenpoint Therapeutics develops treatments for age-related eye conditions. Its products are designed to address presbyopia and other vision issues through clinically developed ophthalmic therapies.
Artios
18 Nov 2025
Artios Pharma lands £90m Series D led by SV Health Investors and RA Capital Management to advance DNA damage response therapeutics
Artios Pharma develops cancer treatments that target DNA damage response pathways, focusing on patient groups with limited existing treatment options.
Janus Henderson Investors
More venture news
- 18 Feb 2026
FYLD secures a £30m Series B led by Energy Impact Partners to monitor high-risk infrastructure fieldwork with intelligence platform
Series BIndustrial - 5 Feb 2026
LawhiveLawhive raises £45m Series B led by angel Mitch Rales to speed up legal services for consumers with AI
Series BLegal - 10 Feb 2026
TemTem lands £55m Series B led by Lightspeed Venture Partners to fix the energy market with transaction infrastructure
Series BEnergy
